A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
- Status
- TERMINATED
- Phase
- PHASE1
Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
- Status
- COMPLETED
- Phase
- N/A
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
- Status
- COMPLETED
- Phase
- N/A
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
- Status
- COMPLETED
- Phase
- N/A
Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer
- Status
- COMPLETED
- Phase
- PHASE1
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
- Status
- COMPLETED
- Phase
- PHASE4
Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
- Status
- COMPLETED
- Phase
- PHASE2
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Intense Temozolomide in Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
- Status
- COMPLETED
- Phase
- PHASE2